Korean J Urol.  2004 Nov;45(11):1081-1088.

Epidemiological Study for Urologic Cancer in Korea (1998-2002)

• Kim WJ
• Chung JI
• Hong JH
• Kim CS
• Jung SI
• Yoon DK

Abstract

PURPOSE: To evaluate the incidence of urologic cancer in Korea.
MATERIALS AND METHODS
Between January 1998 and December 2002 the Korean Urologic Oncology Society (KUOS) decided to evaluate the incidence of Korean urologic cancer. The URO-DMS data obtained by 86 training hospital was analyzed. First, the disease code was simplified; for example, renal cell carcinoma (C64), and thereafter, evaluated for incidence and prevalence, etc.
RESULTS
A total of 35,480 patients were newly diagnosed over this period. Bladder cancer was the most common (42.9%) urologic cancer, followed by prostate (26.4%), kidney (22.4%), ureter (3.7%), renal pelvis (3.0%), testis (2.8%), penile (0.2%), urethral (0.1%) and scrotal cancers (0.1%). Male patients outnumbered the females by a ratio of 4.4:1. The incidence rates per 100,000 males for prostate and testicular cancers were 7.73 and 0.81, respectively. The incidence rates per 100,000 persons for bladder, renal, ureter and renal pelvis cancers were 6.36, 3.30, 0.55 and 0.44, respectively. Cancers of the prostate and kidney increased rapidly, but the others increased steadily.
CONCLUSIONS
It is hoped that these results would contribute to cancer research and control of cancers in Korea.

Keyword

Urologic cancer; Incidence

MeSH Terms

Carcinoma, Renal Cell
Epidemiologic Studies*
Female
Hope
Humans
Incidence
Kidney
Kidney Pelvis
Korea*
Male
Prevalence
Prostate
Testicular Neoplasms
Testis
Ureter
Urinary Bladder
Urinary Bladder Neoplasms
Urologic Neoplasms*